Adverse events in the liposomal-therapy group were infusion-related fever or rigors ( in 40 % ) and increased anemia or thrombocytopenia ( in 2 % ) ; such events in the conventional-therapy group were fever or rigors ( in 64 % ) , increased anemia ( in 19 % ) , and hypokalemia ( in 2 % ) .
